A large-scale genetic study has uncovered a surprisingly common recessive cause of neurodevelopmental disorders, revealing how hidden changes in small RNA genes can disrupt brain development and open new avenues for diagnosis and family counseling.
Research: Biallelic mutations in RNU2-2 cause the most common recessive neurodevelopmental disorder known. Image credit: Lightspring / Shutterstock
In a recent study published in natural geneticsA group of researchers identified and characterized a recessive neurodevelopmental disorder caused by biallelic mutations in the RNU2-2 gene and investigated its clinical and molecular features.
background
Neurodevelopmental disorders affect millions of children worldwide and often lead to lifelong cognitive, behavioral, and physical problems. Although many cases remain genetically unexplained, advances in sequencing have revealed that even small non-coding ribonucleic acids (RNAs), such as small nuclear RNAs (snRNAs), play important roles in brain development.
RNA splicing requires the help of non-coding RNA. Therefore, they are very important for the overall function of RNA. The possibility that alterations in the splicing process play a role in disease development has not been well studied.
Identifying how changes in non-coding RNA genes influence neurological diseases is essential to provide diagnostic tools to clinicians and guide the development of future treatments. There are large knowledge gaps regarding the genetic basis of the disease, and further research is needed to fill them.
About research
Researchers conducted a large-scale genetic association study using data from the 100,000 Genomes Project (100KGP), Genome Medical Services (GMS), and National Genome Research Library (NGRL).
The analysis included 14,805 people with neurodevelopmental disorders and 52,861 controls without such conditions. A statistical method, Bayesian Evaluation of Mutation Involvement in Mendelian Diseases (BeviMed), was applied to identify rare mutations associated with the disease.
Researchers analyzed RNU2-2 gene variants using dominant and recessive models. Readback phasing techniques were used to determine whether mutations occur on the same chromosome (cis) or on different chromosomes (trans), allowing for discrimination in biallelic cases. Variants were classified according to their potential to cause disease.
Independent datasets of participants from the Undiagnosed Disease Network (UDN), the Undiagnosed Patients Program (UPP), and the Erasmus Medical Center (Erasmus MC) were also analyzed to confirm the results. Clinical phenotypes were assessed according to Human Phenotype Ontology (HPO) terminology. Additionally, whole blood RNA sequencing (RNA-seq) data from selected participants were analyzed to determine gene expression levels and investigate the molecular mechanisms underlying the disease.
Research results
This study identified strong statistical evidence for an association between biallelic variations in the RNU2-2 gene and recessive neurodevelopmental disorders. The high log Bayes factor of 18.2 supports a recessive genetic model and indicates a robust association. Researchers identified 18 high-confidence probands (tier 1), an additional 5 affected siblings, and 13 less-confident potential probands (tier 2).
Laboratory tests showed a common core pattern of symptoms rather than completely homogeneous symptoms, as the majority of affected individuals had intellectual disability, global developmental delay, and seizures. Seizure disorders were present in more than 90% of Tier 1 cases in the 100KGP cohort. Developmental delay and associated neurological features were also common in affected individuals. Additional diagnostic findings include electroencephalogram abnormalities, movement disorders, and skeletal abnormalities, including microcephaly.
Replication among independent cohorts further confirmed this result. An additional nine cases from an international dataset showed similar genetic and clinical profiles, strengthening confidence in the association. It was also observed that individuals carrying only one mutation did not exhibit symptoms associated with the reported neurodevelopmental disorder, supporting that the disease is recessive.
At the molecular level, RNA sequencing revealed that expression of the mutant RNU2-2 allele in affected individuals was dramatically reduced by more than 90%. However, carriers showed partial compensation due to increased expression of the normal allele. This suggests that the disease arises from a loss-of-function mechanism rather than a toxic gain-of-function mechanism.
Structural modeling predicted that pathogenic mutations impair the critical stem-loop structure of U2-2 snRNA, suggesting an important role for this sequence in spliceosome function. These disruptions are predicted to impair aspects of RNA splicing, an essential process required for correct gene expression. Nevertheless, splicing defects were not consistently detected and may have been missed due to tissue specificity or the limited number of samples available.
This disorder is considered to be one of the most prevalent recessive neurodevelopmental disorders currently diagnosable by sequencing, accounting for approximately 10% of all families with recessive neurodevelopmental disorders currently diagnosable by sequencing, and approximately 60% more frequent than the dominant RNU4-2-associated ReNU syndrome. Furthermore, it has been shown to be prevalent in both consanguineous and non-consanguineous populations, thereby suggesting that it may be an important but under-recognized cause of disease across populations.
conclusion
Biallelic variations in the RNU2-2 gene represent a significant cause of previously underappreciated recessive neurodevelopmental disorders. This finding highlights that non-coding RNAs play an important role in human disease and disruption of the RNA splicing machinery can lead to serious neurological disorders.
Identification of diagnosable diseases with relatively common genotypes has important implications for clinical practice, including genetic counseling in affected families, early diagnosis, and potentially preconception or prenatal genetic counseling.
Reference magazines:
- Green, D., Mendes, R., Lees, J., Barboza, M., Brussels, A., Cigliatti, L., Ferraro, F., Mancini, C., Schott, R., Slotels, F., Bertini, E., Bonner, DE, Bowman, A., Brooks, AS, Cassini, TA, Ezell, KM, Gomez-Ospina, N., Kriefstra, T., Rives, L., . . Touro, E. (2026). Biallelic mutations in RNU2-2 cause the most common recessive neurodevelopmental disorder known. Natural Genetics, 1-8. DOI: 10.1038/s41588-026-02539-5, https://www.nature.com/articles/s41588-026-02539-5
